Review: Revisiting the human cholinergic nucleus of the diagonal band of Broca

• Published in: Neuropathology and applied neurobiology Vol. 44; no. 7; pp. 647 - 662
• Main Authors: Liu, A. K. L., Lim, E. J., Ahmed, I., Chang, R. C.‐C., Pearce, R. K. B., Gentleman, S. M.
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01-12-2018; John Wiley and Sons Inc
• Subjects: Alzheimer Disease - pathology; Alzheimer's disease; Basal forebrain; Cholinergic Neurons - pathology; cholinergic system; Dementia disorders; Diagonal band of Broca; Diagonal Band of Broca - pathology; Forebrain; Hippocampus; Humans; Lewy bodies; Lewy body dementia; Lewy Body Disease - pathology; Literature reviews; Neurodegenerative diseases; Nucleus basalis; Parkinson Disease - pathology; Parkinson's disease; Review; Parkinson's disease; Alzheimer's disease; diagonal band of Broca; Lewy body dementia; basal forebrain; cholinergic system
• ISSN: 0305-1846; 1365-2990
• DOI: 10.1111/nan.12513

Although the nucleus of the vertical limb of the diagonal band of Broca (nvlDBB) is the second largest cholinergic nucleus in the basal forebrain, after the nucleus basalis of Meynert, it has not generally been a focus for studies of neurodegenerative disorders. However, the nvlDBB has an important projection to the hippocampus and discrete lesions of the rostral basal forebrain have been shown to disrupt retrieval memory function, a major deficit seen in patients with Lewy body disorders. One reason for its neglect is that the anatomical boundaries of the nvlDBB are ill defined and this area of the brain is not part of routine diagnostic sampling protocols. We have reviewed the history and anatomy of the nvlDBB and now propose guidelines for distinguishing nvlDBB from other neighbouring cholinergic cell groups for standardizing future clinicopathological work. Thorough review of the literature regarding neurodegenerative conditions reveals inconsistent results in terms of cholinergic neuronal loss within the nvlDBB. This is likely to be due to the use of variable neuronal inclusion criteria and omission of cholinergic immunohistochemical markers. Extrapolating from those studies showing a significant nvlDBB neuronal loss in Lewy body dementia, we propose an anatomical and functional connection between the cholinergic component of the nvlDBB (Ch2) and the CA2 subfield in the hippocampus which may be especially vulnerable in Lewy body disorders.